SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as the community anticipates its mainnet launch, touting its potential to revolutionize global finance and unify blockchains with its anchor technology. Community members are excited about potential Coinbase listings and partnerships, envisioning a significant impact on the crypto landscape. Discussions also highlight Keeta's focus on real-world asset tokenization and regulated finance, distinguishing it from other crypto projects.

Pineapple Financial, Inc. is a Canadian based mortgage technology and brokerage company, which engages in the mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. The company also provides back-office services, together with pre-underwriting support services. The company was founded by Shubha Dasgupta, Kendall Marin, and Charles Andrew Green on October 16, 2015 and is headquartered in North York, Canada.

Pineapple Financial Inc

Pineapple Financial ($PAPL) is trending after a large private placement and a move into Injective (INJ) crypto, sparking excitement about its digital asset strategy. The community is actively discussing potential short squeezes and high price targets, while some caution about possible dilution. With a small float and high borrow costs, the stock's volatility is attracting both bulls and bears.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

Gyrodyne ($GYRO) is trending amid discussions of its low float and potential for a significant breakout, with some traders drawing comparisons to previous high-momentum stocks. The community is closely watching key breakout levels, anticipating a rapid price surge if certain thresholds are breached. Some traders also highlight the company's real estate assets, suggesting they could drive further gains.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community celebrates recent milestones and anticipates upcoming utilities, including staking. Social media is buzzing with excitement as community members express bullish sentiment and encourage others to join the ride. The coin's active community and consistent grind are driving conversations, with many believing $BROKE.X is poised to take over alt season.

SuperCom Ltd. engages in the provision of traditional and digital identity solutions. It offers identification, tracking, and security products to government, private and public organization. It operates through the following divisions: e-Gov, Internet of Things (IoT), and Cyber Security. The e-Gov division provides solutions for traditional and biometrics enrollment, personalization, issuance and border control services. The IoT division products and services reliably identify, track, and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles, and monitored objects. The Cyber Security division is involved in the comprehensive solutions to protect the organization's sensitive data residing on servers, laptops, and detachable devices. The company was founded by Jack Hasan and Eli Rozen on July 4, 1988 and is headquartered in Tel Aviv, Israel.

SuperCom Ltd

SuperCom ($SPCB) is trending due to community discussion around its potential in the electronic monitoring market, highlighted by a recent Seeking Alpha article and new contract wins, including a statewide technology procurement contract with the North Carolina Sheriff's Association. Community talking points revolve around the company's low float, increasing number of contracts, and potential for a significant rise in share price, with some suggesting it could reach $50 or higher. The company's expansion into new states and strategic partnerships are also fueling optimism, along with speculation regarding potential contract opportunities with ICE.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses its potential for growth, particularly around meme coins like BROKE and IMG. There's excitement around treasury developments and potential ETFs. Some users are highlighting Solana's technical advantages and staking opportunities.

BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).   The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.  The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.

Bio Protocol

Bio Protocol ($BIO.X) is trending as the community anticipates another potential surge, with some eyeing a return to previous highs and beyond. Traders are discussing chart patterns and potential breakout points, while also noting recent volatility and possible manipulation. Some community members believe the coin has strong long-term potential.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is trending as investors weigh its defensive qualities amid market volatility, with some highlighting its shift towards value and away from tech. Community discussion revolves around its dividend yield and long-term stability, while others express frustration with its recent performance compared to growth-focused ETFs. There's also chatter about potential impacts from tariffs and upcoming dividend announcements.

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.

Beam Therapeutics Inc

Recent enthusiasm for Beam Therapeutics centers around anticipation for 'September 14', though the specific meaning remains a mystery and a point of speculation within the community.  The stock also saw a jump after RMAT designation for BEAM-101. Community members are actively discussing upcoming catalysts, potential data readouts, and comparing Beam to competitors in the gene editing space.

Tether (USDT) is a cryptocurrency with a value meant to mirror the value of the U.S. dollar. The idea was to create a stable cryptocurrency that can be used like digital dollars. Coins that serve this purpose of being a stable dollar substitute are called “stable coins.” Tether is the most popular stable coin and even acts as a dollar replacement on many popular exchanges! According to their site, Tether converts cash into digital currency, to anchor or “tether” the value of the coin to the price of national currencies like the US dollar, the Euro, and the Yen. Like other cryptos it uses blockchain. Unlike other cryptos, it is [according to the official Tether site] “100% backed by USD” (USD is held in reserve). The primary use of Tether is that it offers some stability to the otherwise volatile crypto space and offers liquidity to exchanges who can’t deal in dollars and with banks (for example to the sometimes controversial but leading exchange Bitfinex).  The digital coins are issued by a company called Tether Limited that is governed by the laws of the British Virgin Islands, according to the legal part of its website. It is incorporated in Hong Kong. It has emerged that Jan Ludovicus van der Velde is the CEO of cryptocurrency exchange Bitfinex, which has been accused of being involved in the price manipulation of bitcoin, as well as tether. Many people trading on exchanges, including Bitfinex, will use tether to buy other cryptocurrencies like bitcoin. Tether Limited argues that using this method to buy virtual currencies allows users to move fiat in and out of an exchange more quickly and cheaply. Also, exchanges typically have rocky relationships with banks, and using Tether is a way to circumvent that.  USDT is fairly simple to use. Once on exchanges like Poloniex or Bittrex, it can be used to purchase Bitcoin and other cryptocurrencies. It can be easily transferred from an exchange to any Omni Layer enabled wallet. Tether has no transaction fees, although external wallets and exchanges may charge one. In order to convert USDT to USD and vise versa through the Tether.to Platform, users must pay a small fee. Buying and selling Tether for Bitcoin can be done through a variety of exchanges like the ones mentioned previously or through the Tether.to platform, which also allows the conversion between USD to and from your bank account.

Tether

Tether is trending due to discussions around its relationship with Rumble, including investments, a potential Rumble wallet integration with USDT, and cloud service partnerships. Community members are also weighing in on Tether's dominance in the stablecoin market and potential regulatory changes affecting its use, particularly the GENIUS Act. There's also discussion around Tether being used in El Salvador, its integration into Bitcoin's Lightning Network, and partnership discussions in Lugano.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of +5.88% and +2.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates

BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of -6.52% and -52.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Misses Revenue Estimates

Kymera Therapeutics (KYMR) delivered earnings and revenue surprises of -14.46% and -66.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates

Vertex (VRTX) delivered earnings and revenue surprises of +6.60% and +2.59%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Regeneron (REGN) Tops Q2 Earnings and Revenue Estimates

Regeneron (REGN) delivered earnings and revenue surprises of +60.52% and +9.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates

Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates

Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates

Crosswalk Therapeutics Announces Acquisition of Rare Disease Assets from Codexis, Inc.

Crosswalk Therapeutics Announces Acquisition of Rare Disease Assets from Codexis, Inc. Crosswalk Therapeutics Announces Acquisition of Rare Disease Assets from Codexis, Inc. PR Newswire CAMBRIDGE...

Codexis, Inc. (NASDAQ:CDXS) Sees Significant Decrease in Short Interest

Codexis, Inc. (NASDAQ:CDXS - Get Free Report) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 2,290,000 shares, a decrease of...

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Current Price	$2.42
Prev Close	$2.42
Open	$2.44
Dividend Yield	0.00%
50-Day Moving Average	$2.81
Beta	2.06
Avg. Volume	1.29M
PE Ratio	-2.95

52-Week High	$6.08
52-Week Low	$1.90
Market Capitalization	$218.45M
EPS (Annual)	-$0.8892
Price to Book	3.93
Revenue Per Employee	$315,664.89
Enterprise Value/EBITDA	N/A

CDXS
Codexis Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CDXS News

CDXS Codexis Inc.